Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Sarepta Slammed By Double Blow: Elevidys Sales Miss, Prasad’s CBER Appointment
Valuation Down 42.3% Over Two Days
May 07 2025
•
By
Mandy Jackson
Sarepta faced a one-two punch on 6 May when it reported Q1 earnings
(Shutterstock)
More from Earnings
More from Scrip